ATE135224T1 - Topisch anzuwendendes pulverförmiges arzneimittel, das zyklische amp-derivate enthält - Google Patents

Topisch anzuwendendes pulverförmiges arzneimittel, das zyklische amp-derivate enthält

Info

Publication number
ATE135224T1
ATE135224T1 AT91116455T AT91116455T ATE135224T1 AT E135224 T1 ATE135224 T1 AT E135224T1 AT 91116455 T AT91116455 T AT 91116455T AT 91116455 T AT91116455 T AT 91116455T AT E135224 T1 ATE135224 T1 AT E135224T1
Authority
AT
Austria
Prior art keywords
topical
cyclic amp
product containing
containing cyclic
medicinal product
Prior art date
Application number
AT91116455T
Other languages
English (en)
Inventor
Norio Takasugi
Eiichi Mafune
Toshiyuki Takayasu
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE135224T1 publication Critical patent/ATE135224T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12Face or body powders for grooming, adorning or absorbing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT91116455T 1990-09-28 1991-09-26 Topisch anzuwendendes pulverförmiges arzneimittel, das zyklische amp-derivate enthält ATE135224T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25699190 1990-09-28

Publications (1)

Publication Number Publication Date
ATE135224T1 true ATE135224T1 (de) 1996-03-15

Family

ID=17300207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91116455T ATE135224T1 (de) 1990-09-28 1991-09-26 Topisch anzuwendendes pulverförmiges arzneimittel, das zyklische amp-derivate enthält

Country Status (8)

Country Link
US (2) US5405838A (de)
EP (1) EP0477943B1 (de)
JP (1) JP3454836B2 (de)
KR (1) KR0178796B1 (de)
AT (1) ATE135224T1 (de)
CA (1) CA2052193A1 (de)
DE (1) DE69117853T2 (de)
DK (1) DK0477943T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3783104B2 (ja) * 2004-03-31 2006-06-07 小林製薬株式会社 抗真菌性外用組成物
AU2008325219A1 (en) * 2007-11-05 2009-05-14 Puretech Ventures Methods, kits, and compositions for administering pharmaceutical compounds
AU2011338530B2 (en) 2010-12-06 2017-06-15 Follica, Inc. Methods for treating baldness and promoting hair growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS497414A (de) * 1972-05-24 1974-01-23
US3849553A (en) * 1973-09-04 1974-11-19 Nelson Res & Dev Cyclic nucleotide therapeutic preparation
US4369181A (en) * 1981-08-05 1983-01-18 Sri International Process for treating proliferative skin diseases using certain 6,8-substituted ribofuranosylpurine-3',5'-cyclic phosphates
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
DE3786714T2 (de) * 1986-06-16 1994-03-10 Daiichi Seiyaku Co Therapeutisches Mittel für Hautgeschwüre.
JPH0759514B2 (ja) * 1986-12-18 1995-06-28 第一製薬株式会社 黄疸治療剤
CA1322957C (en) * 1988-03-30 1993-10-12 Hitoshi Yamauchi Cyclic amp derivative ointments

Also Published As

Publication number Publication date
US5424298A (en) 1995-06-13
EP0477943A1 (de) 1992-04-01
JP3454836B2 (ja) 2003-10-06
DE69117853D1 (de) 1996-04-18
EP0477943B1 (de) 1996-03-13
DK0477943T3 (da) 1996-07-22
KR920005989A (ko) 1992-04-27
CA2052193A1 (en) 1992-03-29
US5405838A (en) 1995-04-11
DE69117853T2 (de) 1996-09-12
JPH05186352A (ja) 1993-07-27
KR0178796B1 (ko) 1999-03-20

Similar Documents

Publication Publication Date Title
DE2862340D1 (en) Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
ZA791732B (en) Carbazolyl-(4)-oxypropanolamine derivatives,preparation thereof and pharmaceutical compositions containing these compounds
DE2861318D1 (en) New derivatives of 4-phenyl-2-(2',2',2-trichlorethoxycarboxamido)-thiazole useful as medicaments, pharmaceutical compositions containing them and process for the preparation of these compounds
IL54373A (en) 5-(4-(diarylmethyl)-1-piperazinylalkyl)benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL99393A0 (en) Thiazolidine derivatives,methods for the preparation thereof and pharmaceutical composition containing the same
DE3062586D1 (en) 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same
DE2862445D1 (en) Hydantoin derivatives and salts thereof, their synthesis and pharmaceutical formulations
IL51403A0 (en) 1,2-dithiole derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL42781A (en) Derivatives of(4'-(3"-indolyl)piperidino)alkylarylketones,process for preparing them and pharmaceutical compositions containing same
IL51402A0 (en) 1,2-dithiole derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
NO172490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater
ZA897541B (en) Benzoxazolinone derivatives,process for the preparation thereof and pharmaceutical compositions containing them
GB2044259B (en) Imidazole derivatives and salts thereof synthesis and pharmaceutical formulations
DE68901859D1 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
NL184833C (nl) 2-gesubstitueerd aminopyrimidinederivaten en farmaceutische preparaten die ze bevatten.
FR2324608A1 (fr) Derives de l'hydroxy-4 cyclopentene-2-one-1 utilisables pour la fabrication de medicaments, et preparation de ces substances
IL58676A (en) Histamine h2-antagonist pyrimid-4-one derivatives,their preparation and pharmaceutical compositions containing same
ATE135224T1 (de) Topisch anzuwendendes pulverförmiges arzneimittel, das zyklische amp-derivate enthält
IL49931A (en) Pharmaceutical compositions comprising 1-phenyl-2,3,4,5-tetrahydro-1h-benzazepine derivatives and certain new such compounds
IL61175A (en) 4-(3-(1,2,3,4-tetrahydro-2-isoquinolyl)-2-hydroxypropyl)delta 2-1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them
NZ193268A (en) 2-(pyrid-2-yl)-tetrahydrothiophene derivatives and pharmaceutical compositions
SE7808234L (sv) Nya dibenso(d,g)(1,3,6)dioxazocinderivat, sett for deras framstellning och lekemedelspreparat innehallande dessa foreningar
DE69101145D1 (de) (alkylthio-3-propyl)-3-benzothiazolinderivate, ihre herstellung und diese enthaltende arzneimittel.
IL56529A (en) N-benzopyranyl-3,4-dihydro-4-oxo-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide derivatives,their manufacture and pharmaceutical compositions containing them
NL7904772A (nl) Fenanthreenderivaten en werkwijze voor het bereiden van deze derivaten en van geneesmiddelen die ze bevatten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee